Use of MPH hemostatic powder for electrophysiology device implantation reduces postoperative rates of pocket hematoma and infection

References

• Voigt A, Shalaby A, Saba S. Continued rise in rates of cardiovascular implantable electronic device infections in the United States: temporal trends and causative insights. Pacing Clin Electrophysiol 2010;33:414-19
   PubMed Web of Science ®Google Scholar
• Padfield GJ, Steinberg C, Bennett MT, et al. Preventing cardiac implantable electronic device infections. Heart Rhythm 2015;12:2344-56
   PubMed Web of Science ®Google Scholar
• Ann HW, Ahn JY, Jeon YD, et al. Incidence of and risk factors for infectious complications in patients with cardiac device implantation. Int J Infect Dis 2015;36:9-14
   PubMed Web of Science ®Google Scholar
• Uslan DZ, Tleyjeh IM, Baddour LM, et al. Temporal trends in permanent pacemaker implantation: a population-based study. Am Heart J 2008;155:896-903
   PubMed Web of Science ®Google Scholar
• Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol 2008;51:e1-62
   PubMed Web of Science ®Google Scholar
• Greenspon AJ, Patel JD, Lau E, et al. 16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008. J Am Coll Cardiol 2011;58:1001-6
   PubMed Web of Science ®Google Scholar
• Gupta N, Kiley ML, Anthony F, et al. Multi-center, community-based cardiac implantable electronic devices registry: population, device utilization, and outcomes. J Am Heart Assoc 2016;5
   Web of Science ®Google Scholar
• Polyzos KA, Konstantelias AA, Falagas ME. Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis. Europace 2015;17:767-77
   PubMed Web of Science ®Google Scholar
• Essebag V, Verma A, Healey JS, et al. Clinically significant pocket hematoma increases long-term risk of device infection: BRUISE CONTROL INFECTION study. J Am Coll Cardiol 2016;67:1300-8
   PubMed Web of Science ®Google Scholar
• Milic DJ, Perisic ZD, Zivic SS, et al. Prevention of pocket related complications with fibrin sealant in patients undergoing pacemaker implantation who are receiving anticoagulant treatment. Europace 2005;7:374-9
   PubMed Web of Science ®Google Scholar
• Lakkireddy D, Pillarisetti J, Atkins D, et al. IMpact of pocKet rEvision on the rate of InfecTion and other CompLications in patients rEquiring pocket mAnipulation for generator replacement and/or lead replacement or revisioN (MAKE IT CLEAN): a prospective randomized study. Heart Rhythm 2015;12:950-6
   PubMed Web of Science ®Google Scholar
• Hirsh DS, Bloom HL. Clinical use of antibacterial mesh envelopes in cardiovascular electronic device implantations. Med Devices (Auckl) 2015;8:71-8
   PubMedGoogle Scholar
• Baddour LM, Epstein AE, Erickson CC, et al. Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation 2010;121:458-77
   PubMed Web of Science ®Google Scholar
• supervisors., M.S.o.E.a.c.l., in Dec.11 2007 Easton Assoc. Survey of 24 Eps, 6EP lab Mgrs. And RNs. June 2, 2008. 2007, 2008
   Google Scholar
• Teillant A, Gandra S, Barter D, et al. Potential burden of antibiotic resistance on surgery and cancer chemotherapy antibiotic prophylaxis in the USA: a literature review and modelling study. Lancet Infect Dis 2015;15:1429-37
   PubMed Web of Science ®Google Scholar
• Valentine R, Wormald PJ, Sindwani R. Advances in absorbable biomaterials and nasal packing. Otolaryngol Clin North Am 2009;42:813-28, ix
   PubMedGoogle Scholar
• Murat FJ, Ereth MH, Dong Y, et al. Evaluation of microporous polysaccharide hemospheres as a novel hemostatic agent in open partial nephrectomy: favorable experimental results in the porcine model. J Urol 2004;172:1119-22
   PubMed Web of Science ®Google Scholar
• Humphreys MR, Castle EP, Andrews PE, et al. Microporous polysaccharide hemospheres for management of laparoscopic trocar injury to the spleen. Am J Surg 2008;195:99-103
   PubMed Web of Science ®Google Scholar
• Rajagopal P, Hakim N. The use of a powdered polysaccharide hemostat (HemoStase) in live donor nephrectomies controls bleeding and reduces postoperative complications. Transplant Proc 2011;43:424-6
   PubMed Web of Science ®Google Scholar
• Nunez-Nateras R, Hurd KJ, Ferrigni EN, et al. Athermal nerve sparing robot-assisted radical prostatectomy: initial experience with microporous polysaccharide hemospheres as a topical hemostatic agent. World J Urol 2013;31:523-7
   PubMed Web of Science ®Google Scholar
• Hamdi G, Ponchel G. Enzymatic degradation of epichlorohydrin crosslinked starch microspheres by alpha-amylase. Pharm Res 1999;16:867-75
   PubMed Web of Science ®Google Scholar
• Chamis AL, Peterson GE, Cabell CH, et al. Staphylococcus aureus bacteremia in patients with permanent pacemakers or implantable cardioverter-defibrillators. Circulation 2001;104:1029-33
   PubMed Web of Science ®Google Scholar
• Sticherling C, Marin F, Birnie D, et al. Antithrombotic management in patients undergoing electrophysiological procedures: a European Heart Rhythm Association (EHRA) position document endorsed by the ESC Working Group Thrombosis, Heart Rhythm Society (HRS), and Asia Pacific Heart Rhythm Society (APHRS). Europace 2015;17:1197-214
   PubMed Web of Science ®Google Scholar
• Indranill Basu-Ray JL, Jia X, Gold M, et al. Subcutaneous versus transvenous implantable defibrillator therapy a meta-analysis of case–control studies. JACC: Clinical Electrophysiology 2017;26;3(13):1475-83
   Google Scholar
• Benlier E, Tas S, Usta U. Preventing graft loss caused by hematoma: experimental study. J Burn Care Res 2014;35:528-33
   PubMed Web of Science ®Google Scholar
• Waragai T, Morgan G, Ralston T, et al. Vascular hemostasis bandage compared to standard manual compression after cardiac catheterization in children. Catheter Cardiovasc Interv 2011;78:262-6
   PubMed Web of Science ®Google Scholar
• Bruckner BA, Blau LN, Rodriguez L, et al. Microporous polysaccharide hemosphere absorbable hemostat use in cardiothoracic surgical procedures. J Cardiothorac Surg 2014;9:134
   PubMed Web of Science ®Google Scholar
• Tschan CA, Nie M, Schwandt E, et al. Safety and efficacy of microporous polysaccharide hemospheres in neurosurgery. Neurosurgery 2011;69(1 Suppl Operative):ons49-63
   Google Scholar
• Galarza M, Porcar OP, Gazzeri R, et al. Microporous polysaccharide hemospheres (MPH) for cerebral hemostasis: a preliminary report. World Neurosurg 2011;75:491-4
   PubMed Web of Science ®Google Scholar
• Dong Y, Schrader L, Drake JF, et al. Hemostatic dose response of degradable starch micro-spheres (DSM45) as measured by thromboelastography. NATA 2nd Annual Symposium, Berlin, Germany, 2001
   Google Scholar
• Ezzat VA, Lee V, Ahsan S, et al. A systematic review of ICD complications in randomised controlled trials versus registries: is our ‘real-world’ data an underestimation? Open Heart 2015;2:e000198
   PubMed Web of Science ®Google Scholar
• Rohacek M, Baddour LM. Cardiovascular implantable electronic device infections: associated risk factors and prevention. Swiss Med Wkly 2015;145:w14157
   PubMed Web of Science ®Google Scholar
• Ghanbari H, Nallamothu BK, Wang Y, et al. Antithrombotic therapy and outcomes after ICD implantation in patients with atrial fibrillation and coronary artery disease: an analysis from the National Cardiovascular Data Registry (NCDR)(R). J Am Heart Assoc 2015;4(2)
   PubMed Web of Science ®Google Scholar
• Atreya AR, Cook JR, Lindenauer PK. Complications arising from cardiac implantable electrophysiological devices: review of epidemiology, pathogenesis and prevention for the clinician. Postgrad Med 2016;128:223-30
   PubMed Web of Science ®Google Scholar
• Kutinsky IB, Jarandilla R, Jewett M, et al. Risk of hematoma complications after device implant in the clopidogrel era. Circ Arrhythm Electrophysiol 2010;3:312-18
   PubMed Web of Science ®Google Scholar
• Raad D, Irani J, Akl EG, et al. Implantable electrophysiologic cardiac device infections: a risk factor analysis. Eur J Clin Microbiol Infect Dis 2012;31:3015-21
   PubMed Web of Science ®Google Scholar
• KHN: Kaiser Health News [Internet]. c2017 Kaiser Family Foundation. 721 Hospitals Penalized For Patient Safety; 2014 Dec 19 [Cited 2017 Nov 1]. Available from: https://khn.org/news/721-hospitals-penalized-for-patient-safety/
   Google Scholar